Correlation Between Madrigal Pharmaceuticals and Protagonist Therapeutics
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Protagonist Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Protagonist Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Protagonist Therapeutics, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Protagonist Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Protagonist Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Protagonist Therapeutics.
Diversification Opportunities for Madrigal Pharmaceuticals and Protagonist Therapeutics
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Madrigal and Protagonist is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Protagonist Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagonist Therapeutics and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Protagonist Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagonist Therapeutics has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Protagonist Therapeutics go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Protagonist Therapeutics
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 1.84 times more return on investment than Protagonist Therapeutics. However, Madrigal Pharmaceuticals is 1.84 times more volatile than Protagonist Therapeutics. It trades about 0.36 of its potential returns per unit of risk. Protagonist Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 21,067 in Madrigal Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of 13,678 from holding Madrigal Pharmaceuticals or generate 64.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Protagonist Therapeutics
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Protagonist Therapeutics |
Madrigal Pharmaceuticals and Protagonist Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Protagonist Therapeutics
The main advantage of trading using opposite Madrigal Pharmaceuticals and Protagonist Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Protagonist Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagonist Therapeutics will offset losses from the drop in Protagonist Therapeutics' long position.| Madrigal Pharmaceuticals vs. Eliem Therapeutics | Madrigal Pharmaceuticals vs. HCW Biologics | Madrigal Pharmaceuticals vs. Scpharmaceuticals | Madrigal Pharmaceuticals vs. Milestone Pharmaceuticals |
| Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |